Soysome: A Surfactant-Free, Fully Biobased, Self-Assembled Platform for Nanoscale Drug Delivery Applications
- 19 November 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 1 (6), 1830-1841
- https://doi.org/10.1021/acsabm.8b00317
Abstract
A new class of biobased nanocarriers—Soysomes—have been discovered and investigated. These nanocarriers are derived from a synthetically accessible, scalable macromolecule, methoxylated sucrose soyate polyol (MSSP), derived from chemical building blocks obtained from soybean oil and sucrose. We observed for the first time that MSSP, when dissolved in an organic solvent of different polarity and slowly added to an aqueous phase at a predetermined rate under ‘nanoprecipitation’ conditions, will form a stable, self-assembled structure with a size range of 100-200 nm depending on the polarity difference between the precipitating solvent-pairs. Without the aid of poly (ethylene glycol) or of any surfactants, these Soysomes were found to be stable in water for an extended period and can withstand the destabilizing effect of time, temperature and pH. We also found that Soysomes were able to encapsulate and release hydrophobic bioactive compound, such as curcumin. Both MSSP and their self-assembled structures were highly biocompatible, and did not trigger cellular toxicity to mammalian cell lines. Our experiments showed that such 100% biobased, non-cytotoxic material as MSSP and related class of products have the potential for use towards the sustainable manufacturing of drug nanocarriers for biomedical applications.Keywords
Funding Information
- Office of Integrative Activities (OIA-1355466)
- National Institute of General Medical Sciences (P20 GM109024)
This publication has 65 references indexed in Scilit:
- Enhanced Stability of Polymeric Micelles Based on Postfunctionalized Poly(ethylene glycol)-b-poly(γ-propargyl l-glutamate): The Substituent EffectBiomacromolecules, 2012
- More Effective Nanomedicines through Particle DesignSmall, 2011
- Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to ApplicationsNano Letters, 2010
- Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDFCancer Research, 2010
- Doxorubicin and Paclitaxel-Loaded Lipid-Based Nanoparticles Overcome Multidrug Resistance by Inhibiting P-Glycoprotein and Depleting ATPCancer Research, 2009
- Dendrimer−Drug Conjugates for Tailored Intracellular Drug Release Based on Glutathione LevelsBioconjugate Chemistry, 2008
- Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseasesThe International Journal of Biochemistry & Cell Biology, 2008
- Optimization of parameters for semiempirical methods V: Modification of NDDO approximations and application to 70 elementsJournal of Molecular Modeling, 2007
- Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug deliveryBiomaterials, 2006
- Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoProceedings of the National Academy of Sciences, 2006